Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Toshimi Kanbe.
Hypertension | 1983
Toshimi Kanbe; Yasuo Nara; Motoki Tagami; Yukio Yamori
Mechanisms of vascular hypertrophy induced by hypertension were studied in cultured aortic smooth muscle cells from spontaneously hypertensive rats (SHR) and stroke-prone SHR (SHRSP) and compared with those from normotensive Wistar-Kyoto (WKY) rats. Fetal calf serum-stimulated ornithine decarboxylase (ODC) activity of cultured smooth muscle cells was greater in SHR and SHRSP than in WKY. Beta- but not alpha-adrenergic agonist stimulated ODC activity acutely in cultured smooth muscle cells from WKY, and isoprenaline-induced activation was blocked by the beta-blocker, propranolol, and enhanced by the phosphodiesterase inhibitor, 1-methyl-3-isobutylxanthine. These results indicate that cultured vascular smooth muscle cells from SHR and SHRSP are more prone to increase the protein synthesis than those from WKY through the trophic induction of ODC activity and that the regulation of ODC activity by catecholamines is mediated through beta-agonistic effect in cultured smooth muscle cells.
Clinical and Experimental Hypertension | 1981
Yukio Yamori; Ryoichi Horie; Yasuo Nara; Masahiro Kihara; Takehiro Igawa; Toshimi Kanbe; Kazuko Mori; Katsumi Ikeda
Establishment of various models for hypertensive diseases such as spontaneously hypertensive rats (SHR) and stroke-prone SHR (SHRSP) clarified the importance of genetic factors in the pathogenesis of these diseases and further accelerated studies on their genetic mechanisms. Although various biochemical abnormalities have been detected and can be used as biochemical markers in these models, they have not been always closely related to blood pressure in F2 generation obtained by cross breeding between SHR and normotensive Wistar-Kyoto rats. Recent studies indicate that biomembrane abnormalities detected in erythrocytes and other membranes of SHR and SHRSP may not only be biochemical markers but also related to the pathogenesis of hypertensive diseases.
Heart and Vessels | 1988
Yukio Yamori; Takehiro Igawa; Toshimi Kanbe; Yasuo Nara; M Tagami
SummarySmooth muscle cells were isolated and cultured from the aortic media of age-matched, stroke-prone and stroke-resistant spontaneously hypertensive rats (SHRSP, SHRSR: SHRs) and Wistar-Kyoto rats (WKY), and the growth rate of cells from the three strains was compared. Under electron microscopical observation the cells were identified as modified (or synthetic-type) smooth muscle cells. Cells occurring at low densities showed the same morphology for both SHRs and WKY, but cells occurring at higher densities were observed to be smaller in SHRs than in WKY. An analysis of the growth curves of cells showed a significantly enhanced replication rate in cells from SHRs compared with those from WKY, especially in the early passages. In later passages (repeated until the 9th passage), however, this distinction was not clear. These growth characteristics were also confirmed in cells from both 12- and 24-week-old, age-matched SHRs and WKY. We could not find any difference between the growth characteristics of cells from SHRSP and SHRSR. It is possible to hypothesize from these findings that the abnormality relating to hypertension (hypertension being a common characteristic of SHRSR and SHRSP) is found in the smooth muscle cells, and is reflected as an enhanced growth rate when they are exposed to mitogenic stimuli, such as in atherosclerosis.
Archive | 1984
Yukio Yamori; Yasuo Nara; Hiroshi Imafuku; Toshimi Kanbe; Kazuko Mori; Masahiro Kihara; Ryoichi Horie
Recent studies on spontaneously hypertensive rats (SHR) [1] and strokeprone SHR (SHRSP) [2] have brought us both good news and bad news [3]. The bad news is that hypertension and stroke are definitely determined by genetic factors [4]. On the other hand, the good news is that hypertension and stroke can be prevented by modifying environmental factors or by preventive treatments, even if genetic predisposition is strong [3, 5, 6].
Clinical Science | 1981
Yukio Yamori; Takehiro Igawa; Toshimi Kanbe; Masahiro Kihara; Yasuo Nara; Ryoichi Horie
Hypertension | 1984
Yukio Yamori; T Igawa; Motoki Tagami; Toshimi Kanbe; Yasuo Nara; Masahiro Kihara; Ryoichi Horie
Clinical Science | 1982
Yukio Yamori; Yasuo Nara; Toshimi Kanbe; H. Imafuku; K. Mori; Masahiro Kihara; Ryoichi Horie
Clinical Science | 1982
Yasuo Nara; Masahiro Kihara; Toshimi Kanbe; Ryoichi Horie; Yukio Yamori
Japanese Heart Journal | 1982
Yukio Yamori; Toshimi Kanbe; Yasuo Nara; Masahiro Kihara; Ryoichi Horie
Japanese Heart Journal | 1984
Yukio Yamori; Takehiro Igawa; Toshimi Kanbe; Motoki Tagami; Masahiro Kihara; Yasuo Nara; Keigo Fujiwara; Ryoichi Horie